Type 2 diabetes trials recruiting in Virginia

All Type 2 diabetes trials nationally

Cities in Virginia

Recruiting trials in Virginia

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Manassas, Suffolk
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Midlothian
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Arlington
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Arlington, Newport News
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
  NCT06112418 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · Virginia: Richmond
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Newport News, Richmond
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
  NCT07282613 · Phase: Phase 3 · Ages: 10 Years to 18 Years · Sex: All (male and female) · Virginia: Charlottesville
• A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
  NCT04786262 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Virginia: Richmond
• A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
  NCT07654374 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Virginia: Burke, Manassas, Suffolk
• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
  NCT07340320 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Vienna
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
  NCT07321886 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Norfolk
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
  NCT07215559 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Norfolk, Richmond
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Hampton
• A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
  NCT07776509 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Manassas
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Arlington
• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
  NCT07219602 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Burke, Manassas
• A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
  NCT07662213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Leesburg, Norfolk
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Danville
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
  NCT07595549 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Norfolk
• A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
  NCT07754461 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Newport News
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Richmond
• AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
  NCT07797335 · Phase: Phase 3 · Ages: 45 Years and older · Sex: All (male and female) · Virginia: Manassas, Richmond, Salem, Winchester
• Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
  NCT05142189 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Fairfax
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Falls Church, Manassas, Norfolk, Richmond
• Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
  NCT03883412 · Phase: Phase 4 · Ages: 21 Years to 60 Years · Sex: All (male and female) · Virginia: Charlottesville
• Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
  NCT07521475 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Newport News
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Virginia: Manassas
• HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
  NCT07546929 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Burke, Midlothian
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
  NCT05390892 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Virginia: Manassas
• Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
  NCT07063420 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Charlottesville
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
  NCT07502508 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Virginia: Burke
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
  NCT07502495 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Manassas
• Potatoes, Type 2 Diabetes, and Cardiometabolic Health
  NCT07229482 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 70 Years · Sex: All (male and female) · Virginia: Blacksburg
• Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
  NCT06681428 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Salem
• Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
  NCT04791371 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 55 Years · Sex: All (male and female) · Virginia: Charlottesville
• Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
  NCT07527650 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Manassas
• Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
  NCT05766735 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 80 Years · Sex: All (male and female) · Virginia: Charlottesville
• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
  NCT07296484 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Suffolk, Vienna